Xing Mengjuan,Jin Zhixin,Sun Yang,Zhu Liping,Treatment of major depression disorder and bilateral angle-closure glaucoma comorbidity： a case report[J].SICHUAN MENTAL HEALTH,2021,34(6):574-576

Treatment of major depression disorder and bilateral angle-closure glaucoma comorbidity： a case report

DOI：10.11886/scjsws20210606002

English keywords:Major depression disorder Angle-closure glaucoma Selective serotonin reuptake inhibitors

Fund projects:上海市“科技创新行动计划”医学创新研究专项（项目名称：基于肠道菌群的泻心汤治疗奥氮平所致代谢综合征的临床研究，项目编号：21Y11921200）；上海市医学创新计划项目（项目名称：调胃承气汤治疗奥氮平所致代谢综合征的临床研究，项目编号：17401932600；项目名称：天麻钩藤饮治疗阿立哌唑所致锥体外系副反应的临床研究，项目编号：16401934700）

Author Name	Affiliation	Postcode
Xing Mengjuan	Shanghai Mental Health Center， Shanghai Jiao Tong University School of Medicine， Shanghai 201108， China	201108
Jin Zhixin	Shanghai Mental Health Center， Shanghai Jiao Tong University School of Medicine， Shanghai 201108， China	201108
Sun Yang	Shanghai Mental Health Center， Shanghai Jiao Tong University School of Medicine， Shanghai 201108， China	201108
Zhu Liping	Shanghai Mental Health Center， Shanghai Jiao Tong University School of Medicine， Shanghai 201108， China	201108

Hits:

Download times:

English abstract:

The purpose of this study is to describe the principles in selection and application of antidepressants in patients with depression complicating glaucoma or at high risk of glaucoma. With the aim of providing a partial reference for relevant issues， this paper elaborated a case of major depression after glaucoma surgery receiving 6 weeks of treatment with escitalopram oxalate and sulpiride achieved significant improvement in depressive and psychotic symptoms without triggering or exacerbating glaucoma.

View Full Text View/Add Comment Download reader